Trials
Search / Trial NCT05660044

Human Factors Study of Ultrasound Navigation Software for Cardiac Imaging

Launched by ULTRASIGHT · Dec 13, 2022

Apply for Trial

Trial Information

Current as of January 17, 2025

Completed

Keywords

ClinConnect Summary

Participants are healthcare professionals, who are not performing echocardiography on a routine basis. Participants attend a short training session to learn the software, then have a memory-decay period, followed by an individual simulated-use scanning session, lasting up to 60 minutes with a Moderator at the heart institute.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Age 18 and older
  • • Novice users or medical professionals who do not perform echocardiographs as part of their routine job responsibilities.
  • • Have the capacity to understand study risks and consent to be in the study
  • • Be available and willing to participate in the study
  • • Not be employed by the Sponsor or another medical device or pharmaceutical company
  • Exclusion Criteria:
  • • -

Trial Officials

Danny Spiegelstein, MD

Study Director

UltraSight

About Ultrasight

Ultrasight is a pioneering clinical trial sponsor dedicated to advancing medical imaging technologies and enhancing diagnostic capabilities. With a focus on innovative ultrasound solutions, Ultrasight aims to improve patient outcomes through rigorous research and development, clinical validation, and strategic partnerships. The organization is committed to adhering to the highest ethical standards and regulatory compliance, ensuring the safety and efficacy of its products. By leveraging cutting-edge technology and a multidisciplinary approach, Ultrasight strives to transform the landscape of medical imaging and contribute to the future of healthcare.

Locations

Ramat Gan, , Israel

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials